Clinical Trial Update: Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and Infants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating intravenous pantoprazole for gastroesophageal reflux disease in neonates and infants has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: University of Louisville | Conditions: Gastroesophageal Reflux | Phase 1 | Status: COMPLETED